1026 related articles for article (PubMed ID: 11598033)
21. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
[TBL] [Abstract][Full Text] [Related]
22. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18.
Kawakami K; Qureshi MH; Koguchi Y; Zhang T; Okamura H; Kurimoto M; Saito A
Cell Immunol; 1999 Apr; 193(1):9-16. PubMed ID: 10202108
[TBL] [Abstract][Full Text] [Related]
23. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo.
Ito H; Ando K; Nakayama T; Taniguchi M; Ezaki T; Saito K; Takemura M; Sekikawa K; Imawari M; Seishima M; Moriwaki H
Hepatology; 2003 Nov; 38(5):1116-24. PubMed ID: 14578850
[TBL] [Abstract][Full Text] [Related]
24. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
Minagawa M; Iiai T; Sato Y; Yamamoto S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1553-5. PubMed ID: 16315866
[TBL] [Abstract][Full Text] [Related]
25. Role of γδ T cells in α-galactosylceramide-mediated immunity.
Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
[TBL] [Abstract][Full Text] [Related]
26. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.
Kawakami K; Koguchi Y; Qureshi MH; Miyazato A; Yara S; Kinjo Y; Iwakura Y; Takeda K; Akira S; Kurimoto M; Saito A
J Immunol; 2000 Jul; 165(2):941-7. PubMed ID: 10878369
[TBL] [Abstract][Full Text] [Related]
27. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
Kajiwara T; Tomita Y; Okano S; Iwai T; Yasunami Y; Yoshikai Y; Nomoto K; Yasui H; Tominaga R
Transplantation; 2007 Jan; 83(2):184-92. PubMed ID: 17264815
[TBL] [Abstract][Full Text] [Related]
28. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
29. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
30. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
[TBL] [Abstract][Full Text] [Related]
32. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
33. Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
Ohtaki H; Ito H; Ando K; Ishikawa T; Saito K; Imawari M; Yokochi T; Moriwaki H; Seishima M
Biochem Biophys Res Commun; 2009 Jan; 378(3):579-83. PubMed ID: 19056341
[TBL] [Abstract][Full Text] [Related]
34. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production.
Kawakami K; Qureshi MH; Zhang T; Okamura H; Kurimoto M; Saito A
J Immunol; 1997 Dec; 159(11):5528-34. PubMed ID: 9548493
[TBL] [Abstract][Full Text] [Related]
35. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.
Micallef MJ; Ohtsuki T; Kohno K; Tanabe F; Ushio S; Namba M; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Fukuda S; Kurimoto M
Eur J Immunol; 1996 Jul; 26(7):1647-51. PubMed ID: 8766574
[TBL] [Abstract][Full Text] [Related]
36. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
37. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
[TBL] [Abstract][Full Text] [Related]
38. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
[TBL] [Abstract][Full Text] [Related]
39. Effect of high fat diet on NKT cell function and NKT cell-mediated regulation of Th1 responses.
Miyazaki Y; Iwabuchi K; Iwata D; Miyazaki A; Kon Y; Niino M; Kikuchi S; Yanagawa Y; Kaer LV; Sasaki H; Onoé K
Scand J Immunol; 2008 Mar; 67(3):230-7. PubMed ID: 18226013
[TBL] [Abstract][Full Text] [Related]
40. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
